Why the study?
Vascular access site complications are the most frequent complications of AF ablation and increase morbidity and hospital stay, prompting assessment of suture-mediated vascular closure devices and same-day discharge.
Does a suture-mediated vascular closure device allow safe early mobilization and same-day discharge in patients undergoing atrial fibrillation ablation?
Population
63 consecutive AF ablation patients (132 access sites)
Comparison
Venous access site closure with a suture-mediated vascular closure device (SVD)
Design
Retrospective observational study
Follow-up
Mean 272 ± 160 days
Key result
Suture-mediated vascular closure devices achieved successful deployment and immediate hemostasis in 94.7% of access sites, with no adverse events over a mean follow-up of 272 days.
Authors
Loading...
May support feasibility in EP access; hypothesis-generating and requires prospective trials before practice change.
Observational (n=63)
Does a suture-mediated vascular closure device allow safe early mobilization and same-day discharge in patients undergoing atrial fibrillation ablation?
Suture-mediated vascular closure devices are safe and effective for achieving rapid hemostasis after AF ablation, facilitating early mobilization and same-day discharge.
Portolés‐Hernández et al. (2021) conducted an observational in Atrial fibrillation (n=63). Suture-mediated vascular closure device (SVD) was evaluated on Successful SVD deployment and immediate hemostasis. Suture-mediated vascular closure devices achieved successful deployment and immediate hemostasis in 94.7% of access sites, with no adverse events over a mean follow-up of 272 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: